Clinical trialNCT03097315CompletedPhase 3Interventional

Suprachoroidal Injection of CLS-TA in Patients With Non-infectious Uveitis

SponsorClearside Biomedical, Inc.Enrollment38PanuveitisUveitisUveitis, AnteriorUveitis, IntermediateUveitis, Posterior

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This open-label study is designed to evaluate the safety of suprachoroidally administered triamcinolone acetone injectable suspension, CLS-TA, in patients with non-infectious uveitis with and without macular edema.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Thomas Ciulla, MD
Clearside Biomedical, Inc.
Study DirectorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Retinal Consultants of Arizona
Phoenix, Arizona, United States
Retina-Vitreous Associates Medical Group
Beverly Hills, California, United States
Northern California Retina Vitreous Associates Medical Group, Inc.
Mountain View, California, United States
Retina Group of Florida
Fort Lauderdale, Florida, United States
Marietta Eye Clinic
Marietta, Georgia, United States
Midwest Eye Retina Practicing at Midwest Eye Institute
Indianapolis, Indiana, United States
Ophthalmic Consultants of Boston
Boston, Massachusetts, United States
Texas Retina Associates
Dallas, Texas, United States
Retina Consultants of Houston
Houston, Texas, United States
Virginia Eye Consultants
Norfolk, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

4 mg CLS-TA Suprachoriodal Injection

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 4 Apr 2017
Primary completion: 24 Jan 2018
Completion: 24 Jan 2018
Last update posted: 23 Jun 2021
Registered enrollment: 38
Registry id: NCT03097315

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.